CASI News and Press, CASI Pharmaceuticals Inc. From 06/10/21

CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma PR Newswire ROCKVILLE, Md. and BEIJING , June 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. b...

In recent years, biomedical research on topics surrounding longevity and aging has gained a tremendous amount of traction. The biotech industry as well as major pharmaceutical companies, have also jumped onto the bandwagon of discovering ways to alter and reverse the aging process. Currently, ...

Recent advances in stem cell technologies, armed with the ability to generate almost any tissue-specific cell types of the body in a dish, human pluripotent stem cells (hPSCs) have drastically moved therapeutic research forward in unprecedented ways. Stem cell-derived cells are increasingly re...

CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare Conference PR Newswire ROCKVILLE, Md. and BEIJING , May 27, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing a...

CASI Pharmaceuticals, Inc. (CASI) Q1 2021 Earnings Conference Call May 13, 2021 08:00 AM ET Company Participants Cynthia Hu - General Counsel & Secretary Dr. Wei-Wu He - Chairman & Chief Executive Officer Larry Zhang - President Dr. Alex Zukiwski - Chief Medical Officer Conference Cal...

“We are bullish on the cell and gene therapy space,” noted BTIG analyst Justin Zelin highlighting the importance of stock picking in the area given “the limited targets and indications to market.”In the area of cell therapy, Zelin initiates the coverage on six comp...

CASI Pharmaceuticals (CASI): Q1 GAAP EPS of -$0.11 misses by $0.05.Revenue of $5.74M (+68.3% Y/Y) beats by $0.69M.As of March 31, 2021, the Company had cash and cash equivalents of $68.1 million compared to $57.1million as of December 31, 2020.Shares +2.07% PM.Press Release For further deta...

CASI Pharmaceuticals Announces First Quarter 2021 Financial Results - EVOMELA First Quarter 2021 Revenue Continues Upward Trend; Poised to Meet Greater Than 50% Revenue Growth Guidance in 2021 - - Expands Pipeline with First-In-Class VCP/p97 Inhibitor for Hematological Malig...

CASI Pharmaceuticals To Report First Quarter 2021 Financial Results And Host Conference Call May 13, 2021 PR Newswire ROCKVILLE, Md. and BEIJING , May 11, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focuse...

Analysts Say These Penny Stocks Are A Buy. Do You Agree? If you’re looking for penny stocks to buy, there are plenty of ways to find them. You could sift through hundreds of charts. There’s also plenty of news and corporate filings to look at. Maybe you want to find top ...